| 摘要 |
The invention relates to a medicine composition for cerebral ischemia treatment as well as to a process of obtaining this composition. The medicine composition comprises 10...11 parts of selenium-treated yeast containing 100 mg Se % 3.5...4 parts of anhydrous extract of Ginkgo biloba leaves containing 150...160 mg ginkgoflavone, 35...37 parts of dextrine, 0.025...0.3 parts of methyl p-hydroxibenzoate, 0.012 parts of propyl p-hydroxibenzoate, 0.03...0.035 parts of magnesium stearate and 0.1...0.11 parts of ascorbic acid, the parts being expressed by weight. According to the invention, the process consists in mixing the liquid extract of Ginkgo biloba with the selenium-treated yeast and the conditioning additives, homogenizing the mixture at high pressure, 450...600 baryes, and dehydrating by atomization at low temperature, 130...140 degree C entrance temperature of drying agent, 70...75 degree C exit temperature of drying agent.
|
